default author photo

Zhiqiang Wu

Government of the People's Republic of China - Department of Molecular Biology and Immunology

China

SCHOLARLY PAPERS

1

DOWNLOADS

105

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22 T Cell Therapy in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Number of pages: 28 Posted: 20 Jul 2019
Hanren Dai, Zhiqiang Wu, Hejin Jia, Chuan Tong, Yelei Guo, Dongdong Ti, Yang Liu, Wenying Zhang, Chunmeng Wang, Yajing Zhang, Meixia Chen, Qingming Yang, Yao Wang and Weidong Han
Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Molecular Biology and Immunology and Zhejiang University - Department of Medical Oncology
Downloads 105 (669,616)

Abstract:

Loading...

Bispecific chimeric antigen receptor, B-cell acute lymphoblastic leukemia, Cell therapy